Skip to main content
. 2024 Feb 26;14:1323422. doi: 10.3389/fonc.2024.1323422

Table 3.

Most relevant DEG discrepancies between Oncopig and human cells in response to gemcitabine treatment.

Cellular Process GENE Function Human Oncopig
Apoptosis Caspase 3 Execution of apoptosis Up No difference
Apoptosis Caspase 10 Execution of apoptosis Up No difference
Apoptosis CASP8AP2 Regulatory role in Fas-mediated apoptosis Up No difference
Apoptosis TP73 Member of the P53 family of transcription factor. Apoptosis response to DNA damage Up No difference
Apoptosis TP53 Tumor suppressor gene. Apoptosis response to DNA damage Down No difference
Apoptosis FAS Member of the TNF-receptor superfamily. Physiological regulation of programmed cell death Up No difference
Apoptosis Rb1 Tumor suppressor gene. Negative regulator of the cell cycle Up No difference
Apoptosis MDM4 Inhibits Tp53 and Tp73-mediated cell cycle arrest and apoptosis No difference Up

Differences in expression are expressed as changes in treated compared to control groups (cells exposed only to medium).